Absence ofFGFR3mutations in urinary bladder tumours of rats and mice treated withN-butyl-N-(-4-hydroxybutyl)nitrosamine-Reference-Cited by-同舟云学术

Absence ofFGFR3mutations in urinary bladder tumours of rats and mice treated withN-butyl-N-(-4-hydroxybutyl)nitrosamine

Published:2005-02-02 Issue:3 Volume:42 Page:142-149
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Dunois-Lardé Claire,Levrel Olivier,Brams Aude,Thiery Jean Paul,Radvanyi François

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference32 articles.

1. The natural history of bladder cancer. Implications for therapy;Lee;Urol Clin North Am,2000

2. Pathways of development and progression in bladder cancer: New correlations between clinical observations and molecular mechanisms;Jones;Semin Urol,1993

3. Two molecular pathways to transitional cell carcinoma of the bladder;Spruck;Cancer Res,1994

4. Molecular alterations in bladder cancer;Cordon-Cardo;Cancer Surv,1998

5. The genetics of transitional cell carcinoma: Progress and potential clinical application;Knowles;BJU Int,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined in vivo model;Molecular Therapy - Nucleic Acids;2023-09

2. FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation;The Journal of Pathology;2018-09-19

3. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype;Science Translational Medicine;2014-07-09

4. FGFR3 Mutations in Epidermal Nevi and Seborrheic Keratoses: Lessons from Urothelium and Skin;Journal of Investigative Dermatology;2007-07